Altria Sues FDA Over Tobacco Product Review Delays
Altria, parent company of Marlboro cigarettes, has filed a lawsuit against the U.S. Food and Drug Administration (FDA), challenging its tobacco product review system. The legal action argues that the current process is delaying new nicotine products from reaching consumers, giving an advantage to foreign competitors who bypass regulations. Altria specifically cited delays in approving its On! nicotine pouches as evidence of regulatory inefficiency. The FDA is required by law to evaluate and decide on applications for new tobacco products within 180 days. However, the lawsuit claims this deadline has never been met, violating legal obligations. The company seeks a court order mandating the development of an updated review system that complies with statutory requirements.
Tickers: $MO